Chancery Trims Suit Over $110M Bioness-Bioventus Deal
Delaware's Court of Chancery on Thursday trimmed down a proposed class action from an Israel-based Bioness Inc. stockholder who challenged the orthopedic device maker's $110 million sale in March 2021 to...To view the full article, register now.
Already a subscriber? Click here to view full article